Global Molecular Diagnostics Market is anticipated to cross USD 22 Billion by the end of year 2025 – Renub Research

Global Molecular Diagnostics Market is anticipated to cross USD 22 Billion by the end of year 2025 - Renub Research

“Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research helps to make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets.”
There are various reasons that will propel the market growth in forecast year; rising incidence rate of infectious disease, increasing incidence rate of cancer of all type, increasing people awareness regarding molecular diagnostic, rapid technological growth, widely acceptance of personalized medicine, increasing healthcare per capita expenditure across the developed and developing nation, accuracy of diagnosis, growing population of cardiovascular and neurological disorder etc.

Molecular Diagnostics Market Share & Global Forecast, By Application, Technology, End User, Regions, Companies (Roche, Abbott, Myriad Genetics, Qiagen, BioMérieux and Others) provides a complete analysis of Molecular Diagnostics Market.

Coronavirus impact on Molecular Diagnostics Market

Molecular diagnostics is the one industry which has directly benefited from COVID-19. Primarily as the number of coronovirus patient numbers begin to surge globally. The governments all over the world in response to the growing COVID-19 pandemic began to start massive testing. We expect in the year 2020, the molecular diagnostics market is expected to grow in double digit CAGR.

According to Renub Research analysis, Global Molecular Diagnostics Market is anticipated to cross USD 22 Billion by the end of year 2025. The major factors that support the market growth are; the prevalence of Infectious diseases (COVID-19) are growing at rapid pace across the world, increasing diagnostic center worldwide, advancement of technology etc.

Molecular diagnostics is a set of methods used to examine Biological genome and proteome markers by applying molecular biology to medical tests— the genetic code of the organism and how their cells express their genes as proteins. During the 1990s, the discovery of newly discovered genes and new DNA sequencing techniques led to the emergence of a distinct field of molecular and genomic laboratory medicine; in 1995, the Molecular Pathology Association (AMP) was formed to give it structure. In vitro biological assays such as PCR-ELISA or in situ fluorescence hybridization are used in molecular diagnostics. The test identifies a molecule that is a disease marker or risk in a sample taken from a patient, often in low concentrations.

The other growth factors of molecular diagnostic market are; rising global economy, increasing healthcare expenditure by public and private partnership model, increasing out of pocket expenditure, expansion of reimbursement policies, increasing healthcare insurance coverage regarding diagnostic, rising consumer awareness regarding molecular diagnostic testing, increasing incidence of influenza, Hepatitis, HIV and others disease etc.

Request a free Sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=global-molecular-diagnostics-market-and-future-forecast-2010-2014-334-p.php

Nowadays, a new diagnostic technique is being practiced in order to combat infectious diseases such as molecular diagnostic testing, which is quite fast and accurate. The number of cancer patients is growing very rapidly, so the demand for molecular diagnostic tests is expected to grow at a rapid pace in the coming time.

Molecular diagnostic is considered as accurate diagnosis over conventional diagnostic technique. Increasing cases of cardiovascular disease and genetic disorder across the world will further propel the market in coming future. Nanopore Technologies ‘ marketing of MinION, an inexpensive and compact sequencer, is ideal for use in small laboratories and point-of-care facilities, which is expected to improve the molecular diagnostics market. The overall prevalence rate of hospital-acquired infections in 2019 was 4.5 percent, and 7.1 percent, respectively, in the U.S. and Europe, according to the WHO. Molecular diagnostics play an essential role in infectious disease research as they provide quick and effective tests.

Market Summary:

The report provides detailed market analysis of molecular diagnostic testing by application in ten parts: infectious diseases, genetic testing, blood screening, oncology, HLA (typing of tissue), microbiology, neurological diseases, pharmacogenomics, cardiovascular diseases, and others.

The market is divided into six parts: PCR, TMA, Hybridization (In-situ Hybridization & FISH), DNA Sequencing & NGS, Microarray and Others. In addition, several factors that influence the growth, challenges and market opportunities in the technological context are analyzed.

The report provides full market analysis through types of end users: Hospitals & Academic Laboratories, Clinics & Commercial Laboratories, and Others. Hospitals & Academic Laboratories will hold in the projected period of time the largest market in the global molecular diagnostic test market.

The report covers 10 global market’s full geographical profile; United States, Europe, India, China, Japan, Brazil, South Korea, Mexico, Russia, and the Rest of the World (ROW).

Renub Research Blog: https://renubresearch.wixsite.com/report

If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.

Browse Related Reports :

United States Biopsy Market
Drug Abuse Testing Market

Contact Us
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com

Key Topics Covered :

1. Executive Summary
2. Global Molecular Diagnostic Market

3. Market Share – Global Molecular Diagnostics

     3.1 By Application
     3.2 By Technology
     3.3 By Countries
     3.4 By Companies

4. Application – Molecular Diagnostics Market

    4.1 Infectious Diseases
    4.2 Blood Screening
    4.3 Oncology / Cancer
    4.4 Genetic Testing
    4.5 HLA (Tissue Typing)
    4.6 Microbiology
    4.7 Cardiovascular Diseases
    4.8 Neurological Diseases
    4.9 Pharmacogenomics
    4.10 Others

5. Technology – Molecular Diagnostics Market

    5.1 PCR
    5.2 Transcription-Mediated Amplification (TMA)
    5.3 Hybridiazation (In-situ Hybridiazation & FISH)
    5.4 DNA Sequencing & NGS
    5.5 Microarray
    5.6 Others

6. Region – Molecular Diagnostics Market

    6.1 United States
    6.2 Europe
    6.3 India
    6.4 China
    6.5 Japan
    6.6 Brazil
    6.7 South Korea
    6.8 Mexico
    6.9 Russia
    6.10 Rest of World (ROW)

7. End Users – Molecular Diagnostics Market

     7.1 Hospitals & Academic Laboratories
     7.2 Clinics and Commercial Laboratories
     7.3 Others

8. Roche Diagnostics – Company Analysis

     8.1 Merger & Acquisitions
     8.2 Sales Analysis

9. Abbott Laboratories – Company Analysis

     9.1 Merger & Acquisitions
     9.2 Sales Analysis

10. Myriad Genetics – Company Analysis

      10.1 Merger & Acquisitions
      10.2 Sales Analysis

11. Qiagen – Company Analysis

      11.1 Merger & Acquisitions
      11.2 Sales Analysis

12. BioMérieux’s Inc – Company Analysis

      12.1 Merger & Acquisitions
      12.2 Sales Analysis

13. Market Drivers

      13.1 Various Developments in the Molecular Diagnostics Landscape
      13.2 Integral to Traditional Labs
      13.3 Improved Assay / Test Efficiencies
      13.4 Targeting Antibiotic Resistance
      13.5 Next Generation Ultrasensitive Molecular Diagnostics
      13.6 Increasing Investment in Genomics & Proteomics Research
      13.7 Technological Advances in Molecular Diagnostics
      13.8 Increasing Acceptance of the Personalized Medicine
      13.9 Growing Molecular Diagnostics for Food Safety

14. Challenges

      14.1 Dearth of Trained Professionals
      14.2 Regulatory Issues
      14.3 Various Factors Slowing Growth of Molecular Diagnostics
      14.4 Reimbursement Capabilities
      14.5 Quality Checkpoints, Awareness & Acceptance

About Us:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Media Contact
Company Name: Renub Research
Contact Person: Rajat Gupta
Email: Send Email
Phone: 16783020700
Address:225 Kristie Ln
City: Roswell
State: GA
Country: United States
Website: www.renub.com/diagnostics-14-c.php